These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 33801734)

  • 1. Rationale, Design, and Feasibility of a Prospective Multicenter Registry Study of Anthracycline-Induced Cardiotoxicity (AIC Registry).
    Inoue K; Iida N; Tajiri K; Bando H; Chiba S; Tasaka N; Nagashio K; Sasamura R; Naito H; Murata M; Li S; Ishizu T; Nakazawa Y; Sekine I; Ieda M
    J Clin Med; 2021 Mar; 10(7):. PubMed ID: 33801734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early Detection and Prediction of Anthracycline-Induced Cardiotoxicity　- A Prospective Cohort Study.
    Inoue K; Machino-Ohtsuka T; Nakazawa Y; Iida N; Sasamura R; Bando H; Chiba S; Tasaka N; Ishizu T; Murakoshi N; Xu D; Sekine I; Tajiri K
    Circ J; 2024 Apr; 88(5):751-759. PubMed ID: 38462534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarkers and Strain Echocardiography for the Detection of Subclinical Cardiotoxicity in Breast Cancer Patients Receiving Anthracyclines.
    Bhagat AA; Kalogeropoulos AP; Baer L; Lacey M; Kort S; Skopicki HA; Butler J; Bloom MW
    J Pers Med; 2023 Dec; 13(12):. PubMed ID: 38138937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two-dimensional speckle tracking echocardiography predicts early subclinical cardiotoxicity associated with anthracycline-trastuzumab chemotherapy in patients with breast cancer.
    Arciniegas Calle MC; Sandhu NP; Xia H; Cha SS; Pellikka PA; Ye Z; Herrmann J; Villarraga HR
    BMC Cancer; 2018 Oct; 18(1):1037. PubMed ID: 30359235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reliability of Left Ventricular Ejection Fraction from Three-Dimensional Echocardiography for Cardiotoxicity Onset Detection in Patients with Breast Cancer.
    Lorenzini C; Lamberti C; Aquilina M; Rocca A; Cortesi P; Corsi C
    J Am Soc Echocardiogr; 2017 Nov; 30(11):1103-1110. PubMed ID: 28822666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anthracycline-Induced Cardiotoxicity in Breast Cancer Patients: A Five-Year Retrospective Study in 10 Centers.
    Gerodias FR; Tan MK; De Guzman A; Bernan A; Locnen SA; Apostol-Alday A; Ybanez EJ; Magno JD; Lim A; Junia A; Mambulao R; Cosare-San Pedro J; Lucero J; Quijano Z; Apurillo J; Uson AJ; Lim JL; Inso CA; Agoncillo-Infante A; Bongcawil RY; Fernando GY; Ramos-Manalaysay AM; Arellano-Simon FA; Ilagan-Cargullo EM; Bago-Azares MJ; Baterna J; Tapispisan JA; Masadao-Rodriguez NM; Tarranza JL; Lista LS; Gumapon JK
    Cardiol Res; 2022 Dec; 13(6):380-392. PubMed ID: 36660064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Impact of Polymorphisms in ATP-Binding Cassette Transporter Genes on Anthracycline-Induced Early Cardiotoxicity in Patients with Breast Cancer.
    Muckiene G; Vaitiekus D; Zaliaduonyte D; Bartnykaite A; Plisiene J; Zabiela V; Juozaityte E; Jurkevicius R
    J Cardiovasc Dev Dis; 2023 May; 10(6):. PubMed ID: 37367397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of biventricular systolic strain derived from the two-dimensional and three-dimensional speckle tracking echocardiography in lymphoma patients after anthracycline therapy.
    Song FY; Shi J; Guo Y; Zhang CJ; Xu YC; Zhang QL; Shu XH; Cheng LL
    Int J Cardiovasc Imaging; 2017 Jun; 33(6):857-868. PubMed ID: 28255826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The value of left ventricular global longitudinal strain assessed by three-dimensional strain imaging in the early detection of anthracyclinemediated cardiotoxicity.
    Mornoş C; Manolis AJ; Cozma D; Kouremenos N; Zacharopoulou I; Ionac A
    Hellenic J Cardiol; 2014; 55(3):235-44. PubMed ID: 24862616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decline in Left Ventricular Ejection Fraction Following Anthracyclines Predicts Trastuzumab Cardiotoxicity.
    Goel S; Liu J; Guo H; Barry W; Bell R; Murray B; Lynch J; Bastick P; Chantrill L; Kiely BE; Abdi E; Rutovitz J; Asghari R; Sullivan A; Harrison M; Kohonen-Corish M; Beith J
    JACC Heart Fail; 2019 Sep; 7(9):795-804. PubMed ID: 31401102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Value of Cardiac Biomarkers Assessment in Combination with Myocardial 2D Strain Echocardiography for Early Detection of Anthracycline-Related Cardiac Toxicity.
    Mahjoob MP; Sheikholeslami SA; Dadras M; Mansouri H; Haghi M; Naderian M; Sadeghi L; Tabary M; Khaheshi I
    Cardiovasc Hematol Disord Drug Targets; 2020; 20(1):74-83. PubMed ID: 31513000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deformation Analysis of Myocardial Layers Detects Early Cardiac Dysfunction after Chemotherapy in Bone Marrow Transplantation Patients: A Continuous and Additive Cardiotoxicity Process.
    Paraskevaidis IA; Makavos G; Tsirigotis P; Psarogiannakopoulos P; Parissis J; Gkirkas K; Pessach I; Ikonomidis I
    J Am Soc Echocardiogr; 2017 Nov; 30(11):1091-1102. PubMed ID: 28864152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three-dimensional speckle-tracking echocardiography for the global and regional assessments of left ventricle myocardial deformation in breast cancer patients treated with anthracyclines.
    Coutinho Cruz M; Moura Branco L; Portugal G; Galrinho A; Timóteo AT; Rio P; Ilhão Moreira R; Mendonça T; Leal A; Gameiro F; Duarte Oliveira S; Luz R; Cruz Ferreira R
    Clin Res Cardiol; 2020 Jun; 109(6):673-684. PubMed ID: 31559482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two-dimensional speckle tracking echocardiography combined with high-sensitive cardiac troponin T in early detection and prediction of cardiotoxicity during epirubicine-based chemotherapy.
    Kang Y; Xu X; Cheng L; Li L; Sun M; Chen H; Pan C; Shu X
    Eur J Heart Fail; 2014 Mar; 16(3):300-8. PubMed ID: 24464946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacodynamic modeling of cardiac biomarkers in breast cancer patients treated with anthracycline and trastuzumab regimens.
    de Vries Schultink AHM; Boekhout AH; Gietema JA; Burylo AM; Dorlo TPC; van Hasselt JGC; Schellens JHM; Huitema ADR
    J Pharmacokinet Pharmacodyn; 2018 Jun; 45(3):431-442. PubMed ID: 29429038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk Factors for Anthracycline-Induced Cardiotoxicity.
    Qiu S; Zhou T; Qiu B; Zhang Y; Zhou Y; Yu H; Zhang J; Liu L; Yuan L; Yang G; Duan Y; Xing C
    Front Cardiovasc Med; 2021; 8():736854. PubMed ID: 34660739
    [No Abstract]   [Full Text] [Related]  

  • 17. Prevention of doxorubicin-induced Cardiotoxicity by pharmacological non-hypoxic myocardial preconditioning based on Docosahexaenoic Acid (DHA) and carvedilol direct antioxidant effects: study protocol for a pilot, randomized, double-blind, controlled trial (CarDHA trial).
    Carrasco R; Ramirez MC; Nes K; Schuster A; Aguayo R; Morales M; Ramos C; Hasson D; Sotomayor CG; Henriquez P; Cortés I; Erazo M; Salas C; Gormaz JG
    Trials; 2020 Feb; 21(1):137. PubMed ID: 32019575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Speckle tracking echocardiography predicts early subclinical anthracycline cardiotoxicity in patients with breast cancer.
    Tang Q; Jiang Y; Xu Y; Xia H
    J Clin Ultrasound; 2017 May; 45(4):222-230. PubMed ID: 27910996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of myocardial performance index and biochemical markers for early detection of anthracycline-induced cardiotoxicity in adults.
    Dodos F; Halbsguth T; Erdmann E; Hoppe UC
    Clin Res Cardiol; 2008 May; 97(5):318-26. PubMed ID: 18193371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variability in echocardiography and MRI for detection of cancer therapy cardiotoxicity.
    Lambert J; Lamacie M; Thampinathan B; Altaha MA; Esmaeilzadeh M; Nolan M; Fresno CU; Somerset E; Amir E; Marwick TH; Wintersperger BJ; Thavendiranathan P
    Heart; 2020 Jun; 106(11):817-823. PubMed ID: 32098808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.